RNAi Advantage Goes To Dicerna

Emily BurkeThe WEEKLY

THE SCIENCE BEHIND THE IPO CRAZE: OUR FOCUS FOR THE NEXT FEW WEEKS I want to thank you for subscribing to Biotech Primer WEEKLY. Now, imagine yourself on the set of Jeopardy! facing this clue: “We saw 45 in 2013, and there’s been 17 so far this year.” The correct response: “What is the number of biotech IPOs?” Alex quips: … Read More